MP
Mary Prabha Rani
About Mary Prabha Rani
Data last updated:
Mary Prabha Rani is a Director at Genex India Bioscience Private Limited (since 2009), Director at Omni Helix Analytics Private Limited (since 2025) and Director at Diagenode Diagnostics India Private Limited (since 2015). The companies operate in Life Sciences and Healthcare. The largest current company by reported revenue is Genex India Bioscience Private Limited at ₹38.64 Cr (FY 2025). Earlier, Mary Prabha Rani was a Director at Bagayam Medical Devices Private Limited (from 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genex India Bioscience Private Limited U51103TN2009PTC072506 | Director | 07 Aug 2009 | 2009 | ₹38.64 Cr (FY 2025) | Active |
 Omni Helix Analytics Private Limited U21004TN2025PTC186179 | Director | 14 Nov 2025 | 2025 | Active | |
| Diagenode Diagnostics India Private Limited U74900TN2015PTC102939 | Director | 09 Nov 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Bagayam Medical Devices Private Limited U74999TN2016PTC113341 | Director | 16 Nov 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mary Prabha Rani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Felix Paul Joe Paul | 02668242 | Genex India Bioscience Private Limited , Omni Helix Analytics Private Limited and 1 more | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mary Prabha Rani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mary Prabha Rani
Mary Prabha Rani currently holds 3 directorships: Genex India Bioscience Private Limited (Director, since 07 Aug 2009, revenue ₹38.64 Cr (FY 2025)); Omni Helix Analytics Private Limited (Director, since 14 Nov 2025); Diagenode Diagnostics India Private Limited (Director, since 09 Nov 2015).
Mary Prabha Rani was first appointed on 07 Aug 2009 as Director at Genex India Bioscience Private Limited. The most recent appointment on record is 14 Nov 2025 at Omni Helix Analytics Private Limited.
Mary Prabha Rani held 1 earlier board appointment: Bagayam Medical Devices Private Limited (Director, from 16 Nov 2016).
The current boards of Mary Prabha Rani's companies include Felix Paul Joe Paul (Genex India Bioscience Private Limited).